Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Mar. 31, 2025	Dec. 31, 2024
ASSETS
Cash and cash equivalents	$ 8,511,477	$ 9,719,310
Grants receivable	595,160	737,282
Prepaid expenses and other current assets	312,210	363,790
Total current assets	9,418,847	10,820,382
Property and equipment, net	842,990	882,445
Operating lease right-of-use asset, net	1,263,855	1,331,577
Total assets	11,525,692	13,034,404
LIABILITIES AND STOCKHOLDERS’ EQUITY
Accounts payable	1,071,802	924,252
Due to affiliates	135,712	178,966
Operating lease liabilities – Current	236,795	230,027
Total current liabilities	1,444,309	1,333,245
Deferred grant reimbursement	110,123	123,579
Operating lease liabilities	1,089,629	1,156,805
Total liabilities	2,644,061	2,613,629
Stockholders’ Equity:
Preferred stock, $0.000001 par value, 5,000,000 shares authorized; no shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively.
Common shares, 100,000,000 authorized shares at $0.000001; 8,367,810 and 8,367,810 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively	8	8
Additional Paid-in-capital	22,684,002	22,366,725
Accumulated (deficit)	(13,802,379)	(11,945,958)
Total stockholders’ equity	8,881,631	10,420,775
Total liabilities and stockholders’ equity	$ 11,525,692	$ 13,034,404

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

Name:	us-gaap_AccountsPayableCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.